Pharma-Bio Serv, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $18.9M | $17.5M |
| FY2022 | — | $16.6M | $14.5M |
| FY2023 | — | $16.1M | $10.4M |
| FY2024 | — | $13.7M | $6.8M |
| FY2025 | — | $11.9M | $3.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $18.9M | $17.5M |
| FY2022 | — | $16.6M | $14.5M |
| FY2023 | — | $16.1M | $10.4M |
| FY2024 | — | $13.7M | $6.8M |
| FY2025 | — | $11.9M | $3.4M |